152 related articles for article (PubMed ID: 28934619)
1. Distinct brain metabolic patterns separately associated with cognition, motor function, and aging in Parkinson's disease dementia.
Ko JH; Katako A; Aljuaid M; Goertzen AL; Borys A; Hobson DE; Kim SM; Lee CS;
Neurobiol Aging; 2017 Dec; 60():81-91. PubMed ID: 28934619
[TBL] [Abstract][Full Text] [Related]
2. Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson's disease.
Perneczky R; Drzezga A; Boecker H; Ceballos-Baumann AO; Granert O; Förstl H; Kurz A; Häussermann P
Dement Geriatr Cogn Disord; 2008; 26(5):475-81. PubMed ID: 18984958
[TBL] [Abstract][Full Text] [Related]
3. Hypoperfusion in Alzheimer's Disease-Prone Regions and Dementia Conversion in Parkinson's Disease.
Chun MY; Lee T; Kim SH; Lee HS; Kim YJ; Lee PH; Sohn YH; Jeong Y; Chung SJ
Clin Nucl Med; 2024 Jun; 49(6):521-528. PubMed ID: 38584352
[TBL] [Abstract][Full Text] [Related]
4. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
Klein JC; Eggers C; Kalbe E; Weisenbach S; Hohmann C; Vollmar S; Baudrexel S; Diederich NJ; Heiss WD; Hilker R
Neurology; 2010 Mar; 74(11):885-92. PubMed ID: 20181924
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic Depletion, β-Amyloid Burden, and Cognition in Lewy Body Disease.
Yoo HS; Lee S; Chung SJ; Lee YH; Lee PH; Sohn YH; Lee S; Yun M; Ye BS
Ann Neurol; 2020 May; 87(5):739-750. PubMed ID: 32078179
[TBL] [Abstract][Full Text] [Related]
6. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
7. Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography.
Brooks DJ
Mov Disord; 2009; 24 Suppl 2():S742-7. PubMed ID: 19877240
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of dementia.
Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
[TBL] [Abstract][Full Text] [Related]
9. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
[TBL] [Abstract][Full Text] [Related]
10. Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with Lewy bodies: implications for cognitive reserve.
Perneczky R; Häussermann P; Drzezga A; Boecker H; Granert O; Feurer R; Förstl H; Kurz A
Am J Geriatr Psychiatry; 2009 Mar; 17(3):188-95. PubMed ID: 19454846
[TBL] [Abstract][Full Text] [Related]
11. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
12. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
Bohnen NI; Koeppe RA; Minoshima S; Giordani B; Albin RL; Frey KA; Kuhl DE
J Nucl Med; 2011 Jun; 52(6):848-55. PubMed ID: 21571793
[TBL] [Abstract][Full Text] [Related]
13. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
Meyer PT; Hellwig S; Amtage F; Rottenburger C; Sahm U; Reuland P; Weber WA; Hüll M
J Nucl Med; 2011 Mar; 52(3):393-400. PubMed ID: 21321269
[TBL] [Abstract][Full Text] [Related]
14. Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease.
Kaasinen V; Rinne JO
Neurosci Biobehav Rev; 2002 Nov; 26(7):785-93. PubMed ID: 12470690
[TBL] [Abstract][Full Text] [Related]
15. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
[TBL] [Abstract][Full Text] [Related]
16. Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson's Disease with Dementia and Dementia with Lewy Bodies.
Takemoto M; Sato K; Hatanaka N; Yamashita T; Ohta Y; Hishikawa N; Abe K
J Alzheimers Dis; 2016; 52(1):205-11. PubMed ID: 27060948
[TBL] [Abstract][Full Text] [Related]
17. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.
Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG
Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501
[TBL] [Abstract][Full Text] [Related]
18. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
[TBL] [Abstract][Full Text] [Related]
19. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
[TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
